MDPI

Targets Template

Write in a clean editor, then format for Targets in one click — DocuGuru applies the official MDPI template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the Targets format

Targets is a peer-reviewed journal published by MDPI, covering Advanced biosensing and bioanalysis techniques, Computational Drug Discovery Methods, Nanoplatforms for cancer theranostics. Over its lifetime it has published 94 papers, which have received 273 citations.

PublisherMDPI
Reference styleNumbered (MDPI)
Numbered — [1], [2] in the text
1. Smith, A.; Jones, B.; Lee, C. A Representative Article Title. Targets 2023, 12, 45–58.

Formats any DOI in Targets style. No sign-up.

Publishes research inAdvanced biosensing and bioanalysis techniques Computational Drug Discovery Methods Nanoplatforms for cancer theranostics Lung Cancer Treatments and Mutations RNA Interference and Gene Delivery
ISSN2813-3137
Citation impact (2-yr)2.93
h-index9
i10-index8
Open accessYes — indexed in DOAJ
Top institutions publishing hereUniversidade do Porto
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in Targets per year

1
2022
7
2023
25
2024
39
2025

Citation impact of Targets by publication year

0
2022
20
2023
128
2024
97
2025

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in Targets

Potential of MMP-2 and MMP-9 Gelatinase Blockade as a Therapeutic Strategy in Fibrosarcoma Treatment: A Decadal Review

Alireza Shoari · 5 Jun 2024

Fibrosarcoma represents a significant challenge in oncology, characterized by high invasiveness and a poor prognosis. Gelatinases, particularly matrix metalloproteinases MMP-2 and MMP-9, play a pivotal role in the degradation of the extracellular matrix, facilitating tumor invasion and metastasis. Inhibiting these enzymes has emerged as a promising therapeutic strategy. This review evaluates the progress in the…

The Role of Resveratrol in Cancer Management: From Monotherapy to Combination Regimens

Eduarda Ribeiro, Nuno Vale · 16 Oct 2024

Resveratrol, a naturally occurring polyphenol found in grapes, berries, and peanuts, has garnered significant attention for its potential anti-cancer properties. This review provides a comprehensive analysis of its role in cancer therapy, both as a standalone treatment and in combination with other therapeutic approaches. This review explores the molecular mechanisms underlying resveratrol’s anti-cancer effects, including…

The Radiant World of Cyanobacterial Phycobiliproteins: Examining Their Structure, Functions, and Biomedical Potentials

Sapana Jha, Varsha K. Singh, Ashish P. Singh et al. · 10 Jan 2024

Phycobiliproteins (PBPs) are accessory light-harvesting pigment complexes found in cyanobacteria, red algae, and certain types of cryptophytes. The unique spectral features (strong absorbance and fluorescence), proteinaceous nature, and some imperative properties such as the anti-oxidative, hepato-protective, anti-inflammatory, and anti-aging activity of PBPs allow their use in biomedical industries. However, basic research and technological innovations are…

Extracellular Vesicle-Associated miRNAs in Cornea Health and Disease: Diagnostic Potential and Therapeutic Implications

Nagendra Verma, Swati Arora, Anurag Kumar Singh et al. · 17 Oct 2025

Extracellular Vesicle-associated microRNAs (EV-miRNAs) are emerging as pivotal regulators of corneal health and disease, holding exceptional promise for transforming both diagnostics and therapeutics. These vesicles carry distinct miRNA signatures in biofluids such as tears, offering a powerful, non-invasive approach for early detection, risk stratification, and dynamic monitoring of corneal disorders. In addition, EV-miRNAs act as…

From Bench to Bedside: Transforming Cancer Therapy with Protease Inhibitors

Alireza Shoari · 3 Mar 2025

Proteases play a pivotal role in cancer progression, facilitating processes such as extracellular matrix degradation, angiogenesis, and metastasis. Consequently, protease inhibitors have emerged as promising therapeutic agents in oncology. This review provides a comprehensive overview of the mechanisms by which protease inhibitors modulate cancer biology, categorizing inhibitors by their target protease classes, including matrix metalloproteinases,…

Targets template — frequently asked questions

How do I write a paper in the Targets format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the Targets template. When you export, DocuGuru compiles the paper into the official MDPI format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does Targets use?
Targets uses Numbered (MDPI) references, shown as numbered [1], [2] markers in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: 1. Smith, A.; Jones, B.; Lee, C. A Representative Article Title. Targets 2023, 12, 45–58.
Do I need to know LaTeX to submit to Targets?
No. DocuGuru generates the mdpi LaTeX class and compiles the PDF for you in the background, so you get a MDPI-ready Targets document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the Targets template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the Targets format with correct headings, figures, tables, and numbered citations.
What is Targets?
Targets - MDPI Journal. It is a multidisciplinary journal, published by MDPI.
Can I export a submission-ready Targets PDF?
Yes — DocuGuru produces a PDF built with the official Targets template (the mdpi class) that is ready to submit to MDPI, together with the matching LaTeX source files.
How much does the Targets template cost?
You can start writing in the Targets template for free. Exporting the final submission-ready Targets PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the Targets template